Skip to main content

Find Clinical Trials

Home
Conditions
Osteosarcoma

Clinical trial condition

Osteosarcoma

Explore clinical trials studying Osteosarcoma. Study availability and eligibility vary by location and protocol.

341 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Osteosarcoma trial results

Completed

Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors

NCT00024258

Conditions: Adnexal Diseases, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +65 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

NCT00161187

Conditions: Adenocarcinoma, Adnexal Diseases, Blast Crisis, +151 more
Locations: Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

View Trial Details

Completed

A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma

NCT00743509

Conditions: Disease Attributes, Neoplasm Metastasis, Neoplasms, +10 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

NCT00002854

Conditions: Adenocarcinoma, Adnexal Diseases, Anus Diseases, +76 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma

NCT01016015

Conditions: Metastatic Osteosarcoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

Northwestern University Chicago, Illinois, United States

View all 24 locations

View Trial Details

Completed

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

NCT00413075

Conditions: Adenoma, Adenosarcoma, Adnexal Diseases, +89 more
Locations: Yale New Haven Hospital New Haven, Connecticut, United States

Columbia University - Herbert Irving Cancer Center New York, United States

New York University Cancer Institute New York, United States

M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

NCT00413322

Conditions: Adenoma, Adenosarcoma, Adnexal Diseases, +92 more
Locations: Mayo Clinic Arizona Scottsdale, Arizona, United States

University of Nebraska Omaha, Nebraska, United States

Portsmouth Regional Hospital Hematology/Oncology Clinic Portsmouth, New Hampshire, United States

View Trial Details

Completed

Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma

NCT01804374

Conditions: Metastatic Osteosarcoma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations: Fondazione del Piemonte per l'Oncologia IRCC Candiolo Candiolo, Torino, Italy

View Trial Details

Completed

Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma

NCT01374672

Conditions: Bone Diseases, Bone Neoplasms, Localized Osteosarcoma, +12 more
Locations: Children's Oncology Group Monrovia, California, United States

View Trial Details

Completed

Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma

NCT01062438

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +4 more
Locations: Not specified

View Trial Details